Sign in

You're signed outSign in or to get full access.

CC

Cineverse Corp. (CNVS)·Q3 2024 Earnings Summary

Executive Summary

  • Q3 FY2025 (quarter ended Dec 31, 2024) was a record quarter: revenue $40.74M, net income to common $7.02M, diluted EPS $0.34, and Adjusted EBITDA $10.82M; direct operating margin at 48% within the 45–50% target .
  • Management said results beat Street consensus on all key metrics: Revenue $40.7M vs $36.4M, Net Income $7.2M vs $5.1M, EPS $0.34 vs $0.31, Adj. EBITDA $10.8M vs $8.2M; S&P Global estimates were unavailable via API at time of query; these consensus figures are management’s disclosure from the call .
  • Terrifier 3 was the key driver (>$54M domestic box office; ~$0.5M P&A), with strong spillover into EST/VOD/physical, and an SVOD premiere on Screambox on Feb 14; management expects a “material” revenue increase in Q4 vs prior year and reiterated 45–50% direct operating margin framework .
  • Balance sheet inflected: as of the call, >$13M cash, zero debt, full $7.5M revolver availability; company is exploring incremental debt to fund slate but “no plans” to issue equity for current operations .
  • Multi-pronged growth engines showed momentum (Cineverse 360 ad network’s biggest month in Oct; SVOD subs ~1.38M; podcast ~15M monthly downloads); management highlighted a “moneyball” theatrical strategy (8–10 wide/specialty releases over time) and expanding AI monetization (Matchpoint Reel Visuals AI) .

What Went Well and What Went Wrong

  • What Went Well

    • Record top- and bottom-line with operating leverage: $40.74M revenue, $7.02M net income to common, $10.82M Adjusted EBITDA; 48% direct operating margin within target range .
    • Terrifier 3 marketing playbook delivered outsized ROI (>$54M domestic box office on sub-$1M lifetime marketing spend) and is catalyzing a repeatable slate (Silent Night Deadly Night in FY3Q next year; The Toxic Avenger on Aug 29, 2025; Wolf Creek: Legacy in 2026) .
    • Ad platform and audience flywheel: Cineverse 360 saw October as biggest month; direct ad sales momentum and studio campaigns (e.g., Focus Features/Nosferatu), with management calling Q3 the largest direct-sold period to date .
    • Management quote: “This was the strongest quarter in the company's history… now completely debt free… and with approximately $13 million in cash-on-hand as of today” .
  • What Went Wrong

    • SG&A rose $3.0M YoY (+47%) due to Terrifier 3-related activity, though management expects normalization as a % of revenue going forward .
    • Direct operating expenses increased $15.5M YoY due to royalties tied to the $27.5M revenue increase—a reminder that royalty-bearing growth constrains drop-through even in blockbuster quarters .
    • Heavy dependence on a single franchise as a principal profit driver; management is addressing concentration risk via a broader slate but execution/box office risk remains (screens targeted ~2,000 per release) .

Financial Results

Metric (USD, except %)Q1 FY2025 (Jun 30, 2024)Q2 FY2025 (Sep 30, 2024)Q3 FY2025 (Dec 31, 2024)
Revenue ($M)$9.13 $12.74 $40.74
Net Income Attributable to Common ($M)$(3.16) $(1.38) $7.02
Diluted EPS ($)$(0.20) $(0.09) $0.34
Adjusted EBITDA ($M)$(1.44) $0.53 $10.82
Direct Operating Margin (%)51% 51% 48%
Adj. EBITDA Margin (%)(15.7%) (calc from )4.2% (calc from )26.6% (calc from )

Actual vs “Consensus” (per management disclosure on the call; SPGI unavailable at query time):

MetricQ3 FY2025 ActualQ3 FY2025 ConsensusSurprise
Revenue ($M)$40.74 $36.40 +$4.34 (Beat)
Net Income ($M)$7.16 (Net income) $5.10 +$2.06 (Beat)
Diluted EPS ($)$0.34 $0.31 +$0.03 (Beat)
Adjusted EBITDA ($M)$10.82 $8.20 +$2.62 (Beat)

Notes: S&P Global consensus could not be retrieved due to rate limits; consensus figures above are those stated by management on the earnings call .

KPIs and Operating Metrics

KPICurrent PeriodPrior Context
Terrifier 3 Domestic Box Office>$54M (cumulative) Opened #1 with ~$19M weekend; re-issue at Christmas; strong EST/VOD/physical
Cineverse 360 Ad Requests>20B CTV ad requests/month; Oct 2024 biggest month to date Platform used by major brands/studios (e.g., Hulu, WB, Konami)
SVOD Subscribers~1.38M (+6% YoY) Screambox +7% last 60 days; Terrifier 2 viewership +45% in Q3
FAST Consumption>2.1B minutes in Q3 Dove +30% YoY; Barney 455M minutes last month
Podcast Downloads~15M monthly; Top-10 network 57 podcasts; bundling lifts fill/CPMs

Guidance Changes

Metric/AreaPeriodPrevious GuidanceCurrent Guidance/CommentaryChange
Direct Operating MarginOngoing45–50% target 48% in Q3; expect 45–50% going forward Maintained
Q4 Revenue OutlookQ4 FY2025N/AExpect “material increase” vs prior year quarter New qualitative
SG&ANear-termFlat/down as % of revenue Q3 elevated due to T3, expected to normalize as % of revenue Clarified
Operating Cash FlowFY2025Positive for FY2025 Reiterated: positive for FY2025 Maintained
Capital StructureCurrent opsN/ANo plans to issue equity for current operations New qualitative
Liquidity/DebtNear-termLOC extended to Sep 2025 Exploring additional debt to expand credit availability; zero balance post-quarter Expanded access

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2)Current Period (Q3)Trend
Theatrical StrategyBuilding “moneyball” slate; T3 marketing blueprint validated; Christmas re-issue planned 8–10 releases over time; 3–4 in the coming fiscal year; target ~2,000 screens avg; slate adds Silent Night Deadly Night (FY3Q), The Toxic Avenger (Aug 29, 2025), Wolf Creek: Legacy (2026) Scaling up, diversifying IP
Ad Platform (C360)20B+ ad requests/month; October record; growing direct sales and non-entertainment advertisers “Biggest” direct-sold quarter; Endeavor-style multi-title studio partnerships under discussion Strong momentum
Streaming & SubsQ2: total subs ~1.36M; strong FAST minutes; Screambox uplift from T2 Subs ~1.38M (+6% YoY); plan to double SVOD growth rate to 15–20% via premium content and CAC investment Accelerating growth focus
Podcast NetworkRapid expansion; Top-10 by audience ~15M monthly downloads; higher fill/CPMs via bundled 360 campaigns; hiring a Head of Podcast Sales Monetization mix improving
AI/TechnologycineSearch public preview; Matchpoint pipeline building; AI rights licensing discussions Matchpoint deals (Multicom, JoySauce); Reel Visuals AI launched; 350k+ hours of represented AI rights; OEM talks for cineSearch Commercializing
Capital AllocationQ2: buyback program; no equity need anticipated with T3 cash flows Debt-free; >$13M cash; exploring debt; no equity for current ops Balance sheet strengthened
Audience InsightsT3 Hispanics = 48% of audience (PostTrak) Data-driven targeting validated

Management Commentary

  • CEO (Chris McGurk): “We had the strongest results this quarter… $40.7 million in revenues… $7.2 million in net income… $10.8 million in adjusted EBITDA… completely debt free… ~$13 million in cash-on-hand as of today.”
  • On slate and model: “We are rapidly filling up our theatrical release slate… These include Silent Night Deadly Night… Toxic Avenger… Wolf Creek: Legacy… with total investments… expected to be less than that of Terrifier 3 for each movie, driven… by our unique blueprint to theatrical marketing.”
  • President/CSO (Erick Opeka): “This quarter underscores how Cineverse is rewriting the rules for content distribution… our direct ad sales business continues to break records… our technology business is expanding rapidly… Matchpoint secured multi-year software services deals… we unveiled Matchpoint Reel Visuals AI.”

Q&A Highlights

  • Release footprint: Targeting ~1,500–2,500 screens per title (avg ~2,000), applying the same targeted playbook as T3; focus on known IP with favorable economics .
  • Genre expansion: Beyond horror, evaluating family, comedy, and other verticals where channel/podcast footprint enables hyper-targeted marketing .
  • Unit economics: Total investment per film (acquisition + marketing) to be <~$5M; partnerships (e.g., STUDIOCANAL) can halve risk; goal is singles/doubles, not swinging for fences .
  • cineSearch monetization: Backend/licensing to OEMs in development; next version targeted within a quarter, with commercialization expected next fiscal year .
  • Podcast monetization: ~15M peak monthly downloads; programmatic fill ~50–55% but rising via 360 bundles and direct sellers; CPMs moving to high-teens/low-20s when bundled .
  • SVOD growth: Aim to lift SVOD growth rate to 15–20% via content/marketing investment (vs prior ~6–7%) .

Estimates Context

  • S&P Global consensus could not be retrieved at time of query due to daily rate limits; management disclosed that Q3 actuals exceeded consensus: Revenue $40.7M vs $36.4M, Net Income $7.2M vs $5.1M, Diluted EPS $0.34 vs $0.31, and Adj. EBITDA $10.8M vs $8.2M .
  • Implication: Estimate revisions likely move higher for Q4 and FY as management called for a “material increase” in Q4 revenue vs prior year and sustained 45–50% direct operating margin; the slate, SVOD acceleration, and ad momentum may support higher outer-year forecasts, tempered by box office execution risk .

Key Takeaways for Investors

  • Structural profitability inflection: Adj. EBITDA margin ~27% in Q3 with 48% direct operating margin; management expects 45–50% direct operating margin ongoing, suggesting a higher earnings base if slate/ad/streaming momentum persists .
  • Replicable theatrical model: Data-driven, low-cost fan activation appears portable to multiple IP-led releases; unit economics (<$5M total investment per title) lower break-even risk and cap downside .
  • Diversified growth engines: C360 ad network scale, Top-10 podcast network monetization, and SVOD growth acceleration create non-box-office levers .
  • AI monetization optionality: Matchpoint SaaS and Reel Visuals AI (350k+ hours represented) offer emerging, potentially higher-margin revenue streams with defensible tech moat .
  • Balance sheet strength: Debt-free with >$13M cash and undrawn $7.5M LOC; no equity issuance planned for current ops; exploring additional debt to fund slate—favorable for dilution risk .
  • Watch near-term catalysts: Screambox SVOD premiere of Terrifier 3 (Feb 14) and potential Pay-1 deal; Q4 revenue inflection; slate announcements and studio ad partnerships .
  • Risks: Franchise concentration/box office variability; royalty-driven COGS; execution in scaling 8–10 releases/year; and conversion of AI/Matchpoint pipeline to revenue .

Appendix: Primary Source References

  • Q3 FY2025 8-K / Press Release and financial statements .
  • Q3 FY2025 Earnings Call (prepared remarks, Q&A, and consensus beat disclosures) .
  • Prior quarters for trend:
    • Q2 FY2025 Press Release and 8-K (financials, KPIs) .
    • Q2 FY2025 Earnings Call (operating context) .
    • Q1 FY2025 Press Release (financials, margins) .
  • Additional relevant press releases during Q3 period:
    • Cineverse 360 ad platform momentum (Oct 2024 biggest month; 20B+ CTV ad requests/month) .
    • Matchpoint Reel Visuals AI launch and AI rights representation scale .
    • Younify integration to enhance cineSearch personalization .
    • Dog Whisperer channel expansion to Samsung TV Plus .
    • Terrifier 3 holiday re-release .